Details for Patent: 8,637,054
✉ Email this page to a colleague
Which drugs does patent 8,637,054 protect, and when does it expire?
Patent 8,637,054 protects IYUZEH and is included in one NDA.
This patent has thirty-four patent family members in twenty-seven countries.
Summary for Patent: 8,637,054
| Title: | Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives |
| Abstract: | This invention concerns an ophthalmic solution including: |
| Inventor(s): | Mercier Fabrice |
| Assignee: | Laboratoires Thea |
| Application Number: | US13595165 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 8,637,054
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thea Pharma | IYUZEH | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 216472-001 | Dec 13, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TOPICAL TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,637,054
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011273549 | ⤷ Try a Trial | |||
| Brazil | 112012033435 | ⤷ Try a Trial | |||
| Canada | 2802816 | ⤷ Try a Trial | |||
| Chile | 2012003684 | ⤷ Try a Trial | |||
| China | 102958509 | ⤷ Try a Trial | |||
| China | 104274396 | ⤷ Try a Trial | |||
| Colombia | 6660508 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
